1. Home
  2. DFNS vs KALA Comparison

DFNS vs KALA Comparison

Compare DFNS & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo T3 Defense Inc. Common Stock

DFNS

T3 Defense Inc. Common Stock

N/A

Current Price

$1.98

Market Cap

4.2M

ML Signal

N/A

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$0.16

Market Cap

3.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFNS
KALA
Founded
2013
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.7M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
DFNS
KALA
Price
$1.98
$0.16
Analyst Decision
Analyst Count
0
0
Target Price
★ $65.00
N/A
AVG Volume (30 Days)
★ 479.6K
324.5K
Earning Date
11-17-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 261.46
67.39
EPS
N/A
★ N/A
Revenue
★ $5,913,461.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$33.09
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.82
$0.07
52 Week High
$335.00
$191.00

Technical Indicators

Market Signals
Indicator
DFNS
KALA
Relative Strength Index (RSI) 22.59 25.43
Support Level N/A $0.11
Resistance Level $7.36 $0.61
Average True Range (ATR) 0.44 0.03
MACD 0.04 0.01
Stochastic Oscillator 0.76 4.15

Price Performance

Historical Comparison
DFNS
KALA

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. The company operates as a strategic platform, building a portfolio of mission-critical suppliers and technology companies. Its portfolio includes businesses involved in defense and aerospace technologies, such as AI software, unmanned aerial systems, electro-mechanical manufacturing, and motion control systems, as well as activities in technology distribution, licensing, and defense infrastructure development through joint ventures.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: